Valproate and valproate-analogues: Potent tools to fight against cancer

被引:87
作者
Blaheta, RA [1 ]
Nau, H [1 ]
Michaelis, M [1 ]
Cinatl, J [1 ]
机构
[1] Univ Frankfurt Klinikum, Interdisziplinares Lab Tumor & Virusforsch, Inst Med Virol, Zentrum Hyg, D-6000 Frankfurt, Germany
关键词
valproic acid; propyl-4-yn-valproic acid; heptyl-4-yn-valproic acid; teratogenicity; anti-turnor effects; HDAC; PPAR;
D O I
10.2174/0929867023369763
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The branched-chain fatty acid valproic acid (VPA) is the most commonly used antiepileptic drug for treating generalized epilepsy. Although originally considered to be of low toxicity, VPA has proved to possess considerable teratogenic potential when applied to the pregnant epileptic women. During the last few years, it has become evident that some of the mechanisms which account for the malformations produced by VPA are related to distinct anti-tumor properties of this compound, This intriguing discovery opens novel aspects for the treatment of tumor patients. In the present review, the biological, biochemical and pharmacological properties of VPA are discussed. Analyses of structure-activity relationships can provide the necessary insight into the molecular structures responsible for the anti-tumor effects.
引用
收藏
页码:1417 / 1433
页数:17
相关论文
共 231 条
[1]   QUANTITATIVE STRUCTURE ANTICONVULSANT ACTIVITY RELATIONSHIPS OF VALPROIC ACID, RELATED CARBOXYLIC-ACIDS AND TETRAZOLES [J].
ABBOTT, FS ;
ACHEAMPONG, AA .
NEUROPHARMACOLOGY, 1988, 27 (03) :287-294
[2]  
Abdul M, 2001, ANTICANCER RES, V21, P2045
[3]   VALIDATION OF AN IN-VITRO TERATOLOGY SYSTEM USING CHIRAL SUBSTANCES - STEREOSELECTIVE TERATOGENICITY OF 4-YN-VALPROIC ACID IN CULTURED MOUSE EMBRYOS [J].
ANDREWS, JE ;
EBRONMCCOY, M ;
BOJIC, U ;
NAU, H ;
KAVLOCK, RJ .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 132 (02) :310-316
[4]  
Andrews JE, 1997, TERATOLOGY, V55, P314, DOI 10.1002/(SICI)1096-9926(199705)55:5<314::AID-TERA3>3.0.CO
[5]  
2-Z
[6]   Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cells [J].
Asghari, V ;
Wang, JF ;
Reiach, JS ;
Young, LT .
MOLECULAR BRAIN RESEARCH, 1998, 58 (1-2) :95-102
[7]   Pharmacokinetics and cerebrospinal fluid penetration of phenylacetate and phenylbutyrate in the nonhuman primate [J].
Berg, S ;
Serabe, B ;
Aleksic, A ;
Bomgaars, L ;
McGuffey, L ;
Dauser, R ;
Durfee, J ;
Nuchtern, J ;
Blaney, S .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 47 (05) :385-390
[8]   Linking colorectal cancer to Wnt signaling [J].
Bienz, M ;
Clevers, H .
CELL, 2000, 103 (02) :311-320
[9]   β-catenin-histone deacetylase interactions regulate the transition of LEF1 from a transcriptional repressor to an activator [J].
Billin, AN ;
Thirlwell, H ;
Ayer, DE .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (18) :6882-6890
[10]   HA-RAS AUGMENTS C-JUN ACTIVITY AND STIMULATES PHOSPHORYLATION OF ITS ACTIVATION DOMAIN [J].
BINETRUY, B ;
SMEAL, T ;
KARIN, M .
NATURE, 1991, 351 (6322) :122-127